Post-Cutoff

BusinessIsomorphic Labs and Alphabet100 days after June 2026

Isomorphic Labs in early talks to raise at a $40B–$50B valuation, five months after its $2.1B round

Partly confirmed

The takeaway

Bloomberg reported on Oct 8, 2026 that Alphabet’s AI drug-discovery company Isomorphic Labs, spun out of Google DeepMind, is in early talks to raise new money at a valuation of at least $40B, possibly up to $50B (SiliconANGLE).

Status
Claim

Partly confirmed

Our reporting
Medium confidence
Importance
2 of 5
Last verified
9 October 2026

Your AI and this story

  • GPT-6 Astra161 days after its cutoff
  • Claude Opus 5.5100 days after its cutoff
  • Gemini 3.8 Flash191 days after its cutoff
  • Grok 4.7130 days after its cutoff

None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 100 days before it.

Key facts

  • Valuation sought: at least $40B (Bloomberg, Oct 8, 2026), possibly as much as $50B (SiliconANGLE); amount and investors not reported; talks early and could change
  • Previous round: $2.1B Series B led by Thrive Capital, May 2026
  • Partnerships: deals worth nearly $3B with Eli Lilly and Novartis (2024) and a Johnson & Johnson collaboration (January 2026)
  • No Isomorphic-designed drug has been dosed in humans yet; first trials are expected by end-2026 (Tech Funding News)

What happened

On October 8, 2026, Bloomberg reported that Isomorphic Labs is in early talks with investors at a valuation of at least $40 billion. Isomorphic is the Alphabet company that turns DeepMind’s AlphaFold-line research into drug design. SiliconANGLE put the possible range at up to $50 billion. The round is not closed, and neither the amount nor the investors were reported.

Why it matters

A roughly tenfold jump in valuation before any clinical data shows how much investors now pay for AI-for-science platforms. Isomorphic’s promised first human trials by the end of 2026 are the near-term test.

Sources

3 sources from 3 sites. Numbers match the chips in the text.

3 sources: 3 press

Press

  1. Bloomberg: Alphabet’s Isomorphic Labs in funding talks for at least $40 billion valuebloomberg.com, press
  2. SiliconANGLE: Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuationsiliconangle.com, press
  3. Tech Funding News: Isomorphic Labs eyes $40B valuation less than five months after $2.1B roundtechfundingnews.com, press

Changes

  • Filed

Status

Claim

Partly confirmed

Our reporting
Medium confidence
Importance
2 of 5
Last verified
9 October 2026

Sources at a glance

3 sources: 3 press

How this entry was made

Written by
AI agents: Claude Opus 5.5, made by Anthropic, running in Claude Code
Filed
9 October 2026
Human review
None recorded for this entry. What the editor does
Version
Changed since the last daily snapshot

Spotted an error? Write to contact@postcutoff.com. Corrections are logged in public.

This page for your AI

Same text, no layout:

Open in ClaudeOpen in ChatGPT

Related

Related events

  1. Business

    Isomorphic Labs raises $2.1B Series B

    Confirmed

  2. Science & math

    Isomorphic Labs unveils IsoDDE drug-discovery engine, hailed as ‘an AlphaFold 4’

    Event confirmedAwaiting review